GSK-2606414
Overview | |
Catalog # | bs-6533c-2mg-solid |
Product Name | GSK-2606414 |
Specifications | |
Storage Buffer | Powder |
Storage Condition | Store in dry, dark place at -20C for 1 year. |
Target | |
Product Information | Molecular Weight: 451.44 Formula: C24 H20 F3 N5 O CAS Number: 1337531-36-8 InChi Key: SIXVRXARNAVBTC-UHFFFAOYSA-N InChi: InChI=1S/C24H20F3N5O/c1-31-12-18(21-22(28)29-13-30-23(21)31)15-5-6-19-16(11-15)7-8-32(19)20(33)10-14-3-2-4-17(9-14)24(25,26)27/h2-6,9,11-13H,7-8,10H2,1H3,(H2,28,29,30) Smiles: CN1C=C(C2C(N)=NC=NC1=2)C1=CC=C2C(CCN2C(=O)CC2=CC(=CC=C2)C(F)(F)F)=C1 Purity: 98.0 Solubility: DMSO: 90 mg/mL(199.36 mM). Appearance: Solid Power Shelf Life: 1.0 years |
Description | GSK-2606414 is an orally available, potent, and selective PERK inhibitor. GSK-2606414 inhibits PERK activation in cells and inhibits the growth of a human tumor xenograft in mice. Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous disease states. Evidence that PERK is implicated in tumorigenesis and cancer cell survival stimulated our search for small molecule inhibitors. |